IBD's rating system ranges from 1 to 99, indicating a stock's performance compared to others. Stocks with an RS Rating of 80 or higher often lead significant market gains. BioNTech stock is forming a consolidation pattern with a 131.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing